alexa The Role of Genome Sequencing in the Identification of
ISSN: 2153-0637

Journal of Glycomics & Lipidomics
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Review Article

The Role of Genome Sequencing in the Identification of Novel Therapeutic Targets

Khalid Khalaf Alharbi1, Imran Ali Khan1, Tejaswini YRSN2,3* and Yadavalli Anurupa Devi4

1Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Saud University, Riyadh, Kingdom of Saudi Arabia

2Vasavi Medical and Research Centre, Khairatabad, Hyderabad, Andhra Pradesh, India

3India Jawaharlal Nehru Technological University, Hyderabad, Andhra Pradesh, India

4Department of Animal Sciences, Hyderabad Central University, Hyderabad, Andhra Pradesh, India

*Corresponding Author:
Tejaswini YRSN
Vasavi Medical and Research Centre
Khairatabad, Hyderabad, Andhra Pradesh, India
E-mail: [email protected]

Received Date: March 18, 2014; Accepted Date: April 01, 2014; Published Date: April 11, 2014

Citation: Alharbi KK, Khan IA, Tejaswini YRSN, Devi YA (2014) The Role of Genome Sequencing in the Identification of Novel Therapeutic Targets. J Glycomics Lipidomics 4:112. doi: 10.4172/2153-0637.1000112

Copyright: © 2014 Alharbi KK, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.



Remarkable technological innovations have emerged in recent years allowing for rapid and cost-effective whole
genome direct sequencing. This generation of massive amounts of genomic data was made with the assumption that
the better understanding of the Genomics would aid in the identification of new causes for genetic disorders, as well as
discovering new therapeutic targets. Due to this assumption, many genomes from different organisms, including humans,
have been sequenced, resulting in an immense amount of genetic data. However, in order to best use this data, a similar
expansion in our ability to process and analyze the data on a large scale will be necessary. The present review focuses
on the impact of genome sequencing projects on the identification of novel genes and proteins, with a special focus on the
role of sequencing pathogenic genomes in potential drug development.

Share This Page

Additional Info

Loading Please wait..
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version